Usability of Nasal Glucagon Device: Partially Randomized Caregiver and Third-Party User Experience Trial with Simulated Administration at a Japanese Site-Reference-Cited by-同舟云学术

Usability of Nasal Glucagon Device: Partially Randomized Caregiver and Third-Party User Experience Trial with Simulated Administration at a Japanese Site

Published:2019-11-04 Issue:1 Volume:11 Page:197-211
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Aranishi Toshihiko^ORCID,Nagai Yukiko,Takita Yasushi,Zhang Shuyu,Nishimura Rimei

Funder

Eli Lilly Japan

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13300-019-00711-1.pdf

Reference19 articles.

1. American Diabetes Association. 6. Glycemic targets: standards of medical care in diabetes—2019. Diabetes Care. 2019;42:S61–70.

2. Kalra S, Mukherjee JJ, Venkataraman S, et al. Hypoglycemia: the neglected complication. Indian J Endocrinol Metab. 2013;17:819–34.

3. Villani M, de Courten B, Zoungas S. Emergency treatment of hypoglycaemia: a guideline and evidence review. Diabet Med. 2017;34:1205–11.

4. Fidler C, Elmelund Christensen T, Gillard S. Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs. J Med Econ. 2011;14:646–55.

5. Nefs G, Pouwer F, Holt RIG, et al. Correlates and outcomes of worries about hypoglycemia in family members of adults with diabetes: the second Diabetes Attitudes, Wishes and Needs (DAWN2) study. J Psychosom Res. 2016;89:69–77.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Intranasal and Injectable Glucagon Administration Among Pediatric Population Responders;Diabetes Technology & Therapeutics;2023-11-01

2. Comparative Serum and Brain Pharmacokinetics of Quercetin after Oral and Nasal Administration to Rats as Lyophilized Complexes with β-Cyclodextrin Derivatives and Their Blends with Mannitol/Lecithin Microparticles;Pharmaceutics;2023-07-28

3. Current Treatment of Pediatric Type 1 Diabetes;Journal of Nihon University Medical Association;2023-06-01

4. Newly discovered knowledge pertaining to glucagon and its clinical applications;Journal of Diabetes Investigation;2023-04-13

5. Dose Rationale of Nasal Glucagon in Japanese Pediatric Patients with Diabetes Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation;Pediatric Drugs;2023-03-27